137 related articles for article (PubMed ID: 2926469)
1. The fate of bone marrow micrometastases in patients with primary breast cancer.
Mansi JL; Berger U; McDonnell T; Pople A; Rayter Z; Gazet JC; Coombes RC
J Clin Oncol; 1989 Apr; 7(4):445-9. PubMed ID: 2926469
[TBL] [Abstract][Full Text] [Related]
2. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
3. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.
Mansi JL; Berger U; Easton D; McDonnell T; Redding WH; Gazet JC; McKinna A; Powles TJ; Coombes RC
Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1093-6. PubMed ID: 3120893
[TBL] [Abstract][Full Text] [Related]
4. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up.
Mansi JL; Easton D; Berger U; Gazet JC; Ford HT; Dearnaley D; Coombes RC
Eur J Cancer; 1991; 27(12):1552-5. PubMed ID: 1782061
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study].
Rack B; Schindlbeck C; Strobl B; Sommer H; Friese K; Janni W
Dtsch Med Wochenschr; 2008 Feb; 133(7):285-9. PubMed ID: 18253918
[TBL] [Abstract][Full Text] [Related]
8. [Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
Funke I; Fries S; Jauch KW
Chirurg; 1991 Nov; 62(11):805-9. PubMed ID: 1769261
[TBL] [Abstract][Full Text] [Related]
9. Detection and management of bone marrow micrometastases in breast cancer.
Osborne MP; Rosen PP
Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
[TBL] [Abstract][Full Text] [Related]
10. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
Cote RJ; Rosen PP; Lesser ML; Old LJ; Osborne MP
J Clin Oncol; 1991 Oct; 9(10):1749-56. PubMed ID: 1919627
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
[TBL] [Abstract][Full Text] [Related]
12. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
Diel IJ; Kaufmann M; Goerner R; Costa SD; Kaul S; Bastert G
J Clin Oncol; 1992 Oct; 10(10):1534-9. PubMed ID: 1403032
[TBL] [Abstract][Full Text] [Related]
13. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow micrometastases and adjuvant treatment of breast cancer.
Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
[TBL] [Abstract][Full Text] [Related]
15. Detection of micrometastases in patients with primary breast cancer.
Redding WH; Coombes RC; Monaghan P; Clink HM; Imrie SF; Dearnaley DP; Ormerod MG; Sloane JP; Gazet JC; Powles TJ
Lancet; 1983 Dec; 2(8362):1271-4. PubMed ID: 6139619
[TBL] [Abstract][Full Text] [Related]
16. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
Merkle E; Bähr J; Henke A; Bühner M; Martus P
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
[TBL] [Abstract][Full Text] [Related]
17. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
[TBL] [Abstract][Full Text] [Related]
18. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
19. [Micrometastases in bone marrow at the time of primary treatment of breast cancer: a new prognostic criterion?].
Untch M; Harbeck N; Eiermann W
Gynakol Rundsch; 1989; 29 Suppl 2():231-3. PubMed ID: 2693244
[No Abstract] [Full Text] [Related]
20. [Micrometastases in bone marrow of patients with cancers in the head and neck area].
Wollenberg B; Ollesch A; Maag K; Funke I; Wilmes E
Laryngorhinootologie; 1994 Feb; 73(2):88-93. PubMed ID: 7512813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
